title: Should moxifloxacin be substituted for isoniazid as a first-line antituberculosis drug?
authors.forename: Prasanta Raghab
authors.initials: PR
authors.lastname: Mohapatra
mesh_terms: D000995:Antitubercular Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001372:Aza Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D004334:Drug Administration Schedule; D024841:Fluoroquinolones; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage / Q000627:therapeutic use*; D000077266:Moxifloxacin; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D011804:Quinolines / Q000008:administration & dosage / Q000627:therapeutic use*; D018088:Tuberculosis, Multidrug-Resistant / Q000517:prevention & control; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy*
chemical_list: D000995:Antitubercular Agents; D001372:Aza Compounds; D024841:Fluoroquinolones; D011804:Quinolines; D000077266:Moxifloxacin; D007538:Isoniazid